An interventional study of Clinical Trial Intervention Description General Study Setup Objective: To compare the efficacy of using a custom-made prefabricated acrylic splint versus no splint in maintaining premaxillary stabilit in Bilateral Complete Cleft Lip And/or Alveolus and Acrylic Splint, and, Maxillary Deficiency and Stability, sponsored by Cairo University. Not yet recruiting. Open to participants aged 9 Years to 13 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-02-10.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
Rationale for conducting the research:
Bilateral alveolar clefts pose significant management challenges, with current treatments like autogenous bone grafting showing instability in up to 40% of cases within a year, risking graft failure and aesthetic issues . Prefabricated acrylic splints may offer a minimally invasive alternative, potentially improving bone graft outcomes and premaxillary stability, crucial for speech, feeding, and respiration. This study evaluates the efficacy of acrylic splinting versus traditional open healing, aiming to enhance patient outcomes and reduce healthcare costs associated with this congenital condition . This research underscores the need for evidence-based, minimally invasive treatments that can improve quality of life and guide clinical practices for managing bilateral alveolar clefts.
Review of literature:
The existing body of literature on bilateral alveolar clefts and their management reflects several inadequacies and gaps in the evidence base. Bilateral alveolar clefts present unique challenges that have not been fully addressed in the literature on cleft lip and palate management. Limited evidence suggests more focused research in this area. The prevailing treatment options for bilateral alveolar clefts predominantly involve surgical bone grafting procedures. These grafting techniques have shown varying success rates, with factors such as graft quality, surgical technique, and premaxillary stability influencing outcomes. However, the specific challenges posed by bilateral alveolar clefts have not been addressed comprehensively in the existing literature. While grafting procedures have undoubtedly improved the lives of countless patients, there remains a need for more targeted interventions that can enhance premaxillary stability and graft success, particularly in the context of bilateral alveolar clefts. The proposed use of prefabricated acrylic splints represents a novel and innovative approach to address these inadequacies. These splints are designed to provide consistent and reliable support to the premaxilla during the critical early phases of healing following grafting procedures. By minimizing premaxillary mobility, they have the potential to enhance graft success rates, improve premaxillary stability, and enhance the overall outcomes of bilateral alveolar cleft repairs.
Explanation for choice of comparators:
standard bone grafting without acrylic splints is considered the 'gold standard' for treating alveolar clefts. Using normal repair as the comparator allows for a clear assessment of the possible advantages and challenges of incorporating acrylic splints into existing best practices.
Aim of the Study The primary aim of this study is to assess the impact of prefabricated acrylic splints on premaxillary stability, soft tissue healing, and graft stability in patients with bilateral alveolar clefts.
Hypothesis:
Null Hypothesis (H0): Bilateral alveolar cleft patients who receive prefabricated acrylic splints have similar premaxillary stability, soft tissue healing, and graft stability.
Alternative Hypothesis (H1): Prefabricated acrylic splints improve premaxillary stability, soft tissue healing, and graft stability in bilateral alveolar cleft patients.
The above hypotheses are neutral and not biased. The study tests these hypotheses to obtain objective and evidence-based conclusions about prefabricated acrylic splints for bilateral alveolar cleft repairs.
This randomized controlled trial will be conducted in Cairo hospital (Abu El-Reesh El-Mounira Children University Hospital). To ensure clinical facilities, medical expertise, and target patient access, this study will be conducted in a hospital. The population density of Cairo and prevalence of bilateral alveolar clefts make it ideal for this research . Cairo study sites will be available upon request and documented in the trial.
Interventions All surgical procedures will be conducted under general anesthesia with nasotracheal intubation, and a first-generation cephalosporin will be administered as antibiotic prophylaxis prior to incision. Autogenous bone grafts will be harvested from the anterior iliac crest using a pediatric minimally invasive technique, involving a 2 cm skin incision made 1 cm lateral to the iliac crest, meticulously dissected to preserve soft tissue. pain management strategies will be employed postoperatively to ensure comprehensive pain control and enhance patient comfort throughout the recovery period.
For the alveolar cleft repair, a sulcular incision will be made to develop full thickness mucoperiosteal advancement flaps extending into the cleft, with careful elevation of buccal flaps above the piriform rim. The bone graft will be contoured to fill the defect, ensuring cortical bone contacts the nasal lining and cancellous bone chips fill remaining spaces. Closure will be performed using interrupted sutures, starting with the nasal floor
Research question:
The primary research question that drives this study is: Does the use of prefabricated acrylic splints increase the stability of the premaxilla and enhance soft tissue healing and graft stability in patients with bilateral alveolar clefts? The above research question uses the PICO (Patient, Intervention, Comparison, Outcome) format to ensure clarity, structure, and focus on the most important aspects of the investigation P - Population: Bilateral alveolar cleft patients I - Intervention: Use of prefabricated acrylic splints C - Comparison: in comparison to the control group that did not use acrylic splints O - Outcome: Enhance premaxillary stability vertical and horizontal assessed by (Lateral Cephalometric Analysis (Radiographically), soft tissue healing, and graft stability
Statement of the problem:
Congenital bilateral alveolar clefts affect many patients from diverse backgrounds, impacting their quality of life . These clefts involve separation of the upper jaw from one alveolus to another, often accompanying cleft lip and palate . Both esthetic and functional issues arise due to impacts on speech, feeding, breathing and appearance from childhood onward . Bone grafting is necessary to reconstruct the maxillary anatomy in bilateral alveolar clefts Premaxillary stability is especially crucial, as it influences bone graft incorporation and craniofacial development . Studies report premaxillary mobility still occurs in 20-40% of treated bilateral clefts at one year post-grafting using standard fixation methods . This instability disrupts integration of autogenous bone grafts and impedes future reconstructive care such as orthodontics . While bone grafting aims to reconstruct the maxilla, premaxilla fixation techniques may remain inadequate to guarantee stability. An alternative is needed to optimize patient outcomes for this patient population.
Rationale for conducting the research:
Bilateral alveolar clefts pose significant management challenges, with current treatments like autogenous bone grafting showing instability in up to 40% of cases within a year, risking graft failure and aesthetic issues . Prefabricated acrylic splints may offer a minimally invasive alternative, potentially improving bone graft outcomes and premaxillary stability, crucial for speech, feeding, and respiration . This study evaluates the efficacy of acrylic splinting versus traditional open healing, aiming to enhance patient outcomes and reduce healthcare costs associated with this congenital condition. This research underscores the need for evidence-based, minimally invasive treatments that can improve quality of life and guide clinical practices for managing bilateral alveolar clefts.
Review of literature:
The existing body of literature on bilateral alveolar clefts and their management reflects several inadequacies and gaps in the evidence base. Bilateral alveolar clefts present unique challenges that have not been fully addressed in the literature on cleft lip and palate management . Limited evidence suggests more focused research in this area. The prevailing treatment options for bilateral alveolar clefts predominantly involve surgical bone grafting procedures. These grafting techniques have shown varying success rates, with factors such as graft quality, surgical technique, and premaxillary stability influencing outcomes. However, the specific challenges posed by bilateral alveolar clefts have not been addressed comprehensively in the existing literature. While grafting procedures have undoubtedly improved the lives of countless patients, there remains a need for more targeted interventions that can enhance premaxillary stability and graft success, particularly in the context of bilateral alveolar clefts . The proposed use of prefabricated acrylic splints represents a novel and innovative approach to address these inadequacies. These splints are designed to provide consistent and reliable support to the premaxilla during the critical early phases of healing following grafting procedures. By minimizing premaxillary mobility, they have the potential to enhance graft success rates, improve premaxillary stability, and enhance the overall outcomes of bilateral alveolar cleft repairs.
Explanation for choice of comparators:
, standard bone grafting without acrylic splints is considered the 'gold standard' for treating alveolar clefts. Using normal repair as the comparator allows for a clear assessment of the possible advantages and challenges of incorporating acrylic splints into existing best practices.
Aim of the Study The primary aim of this study is to assess the impact of prefabricated acrylic splints on premaxillary stability, soft tissue healing, and graft stability in patients with bilateral alveolar clefts.
Hypothesis:
Null Hypothesis (H0): Bilateral alveolar cleft patients who receive prefabricated acrylic splints have similar premaxillary stability, soft tissue healing, and graft stability.
Alternative Hypothesis (H1): Prefabricated acrylic splints improve premaxillary stability, soft tissue healing, and graft stability in bilateral alveolar cleft patients.
The above hypotheses are neutral and not biased. The study tests these hypotheses to obtain objective and evidence-based conclusions about prefabricated acrylic splints for bilateral alveolar cleft repairs.
Allocation Ratio and Framework:
This RCT has a 1:1 allocation ratio, so the control and test groups will each receive the same number of participants. This balanced allocation ensures equal group sizes, reducing bias and enabling a more robust comparison between the two interventions.
Superiority Trial This RCT is a superiority trial to show that prefabricated acrylic splints improve premaxillary stability, soft tissue healing, and graft stability in bilateral alveolar cleft patients. Superiority trials prove the new intervention works better than the control. In this trial, the null hypothesis (H0) states that the two interventions are similar, while the alternative hypothesis (H1) states that prefabricated acrylic splints are better. A superiority trial is needed to determine if the new intervention improves patient outcomes meaningfully and clinically. It is important to determine if prefabricated acrylic splints improve premaxillary stability, soft tissue healing, and graft success in bilateral alveolar cleft patients. A successful superiority trial could support this intervention in clinical practice, improving patient care and outcomes. A 1:1 allocation ratio reduces allocation bias by balancing the study with equal numbers of participants in each group. This design makes control and test group comparisons clear and robust. This trial will inform clinical practice and build knowledge of bilateral alveolar cleft management.
III. Methods
A) Participants, interventions \& outcomes 9. Study settings: This randomized controlled trial will be conducted in Cairo hospital (Abu El-Reesh El-Mounira Children University Hospital). To ensure clinical facilities, medical expertise, and target patient access, this study will be conducted in a hospital. The population density of Cairo and prevalence of bilateral alveolar clefts make it ideal for this research . Cairo study sites will be available upon request and documented in the trial.
A suitable and representative sample will be selected by setting trial participant eligibility criteria. the inclusion and exclusion criteria will consider demographics, disease severity, prior treatment, diagnostics, and other factors. This trial must balance accurately representing the target population with avoiding overly restrictive selection criteria.
Inclusion Criteria
Exclusion Criteria
Inability to provide informed consent or assent.
Operator-dependent interventions will have clear eligibility criteria for care providers and centers to ensure consistency in administration. To improve external validity and clinical applicability, the trial will avoid overly restrictive participant selection . To ensure generalizability, trial participants must reflect the diversity of the target population.
All surgical procedures will be conducted under general anesthesia with nasotracheal intubation, and a first-generation cephalosporin will be administered as antibiotic prophylaxis prior to incision .Autogenous bone grafts will be harvested from the anterior iliac crest using a pediatric minimally invasive technique, involving a 2 cm skin incision made 1 cm lateral to the iliac crest, meticulously dissected to preserve soft tissue. pain management strategies will be employed postoperatively to ensure comprehensive pain control and enhance patient comfort throughout the recovery period.
For the alveolar cleft repair, a sulcular incision will be made to develop full thickness mucoperiosteal advancement flaps extending into the cleft, with careful elevation of buccal flaps above the piriform rim. The bone graft will be contoured to fill the defect, ensuring cortical bone contacts the nasal lining and cancellous bone chips fill remaining spaces. Closure will be performed using interrupted sutures, starting with the nasal floor and followed by oral closure, with a stabilizing horizontal mattress suture for added stability.
Patients will be preoperatively assigned in a 1:1 ratio to receive either a custom-made prefabricated acrylic splint, designed and trimmed using digital software like Mimics for accurate fit and stabilization of the premaxilla , or no splint, allowing for comparison of premaxillary stability between groups. Both groups will follow a standardized postoperative protocol that includes regular follow-up assessments for premaxillary stability, wound healing, and potential complications, using clinical examination and radiographic evaluation. Data collected will be analyzed using statistical methods to compare outcomes between the experimental and control groups, focusing on premaxillary stability as the primary outcome, with wound healing and complications as secondary measures.
The primary outcome should be:
Secondary objectives
This secondary objective aims to quantitatively analyze the extent of bone regeneration following periodontal treatments using Cone Beam Computed Tomography (CBCT). CBCT is a state-of-the-art imaging technology that provides high-resolution, three-dimensional images of the teeth and jawbones. It is particularly valuable in periodontics for assessing bone structure, detecting defects, and monitoring bone density changes over time.
Prioritization of Outcome Outcome Method of Measurement Unit of Measurement Primary outcome
Premaxillary Stability by (Lateral Cephalometric Analysis (Radiographically) Numerical
Secondary outcome Bone Gain and Premaxilla stability Cone Beam Computed Tomography (CBCT) and Periotest Assessment (Clinically) Numerical
Table 1: Example template of the recommended content for the schedule of the activities performed on participants.
Figure.Exmple template of recommended content for the schedule of Enrolment interventions, and assessment Study period Enrolment Allocation Post-allocation Close-out Timepoint t1 (Week 1), t2 (Week 2) t0 (Week 3) t3 (Month 1), t4 (Month 3), t5 (Month 6), t6 (Month 9) t Final (Month 12) Enrolment
Eligibility screen t1 (Week 1) Informed consent t2 (Week 2)
Allocation T0 (week 3) Interventions Intervention A: refabricated acrylic splint at t3 (Month 1) Intervention B: No splint at t3 (Month 1)
Assessments
Baseline Variables: Demographics, cleft severity, prior treatments Captured at t0 (Week 3)
Outcome Variables:
Primary: Premaxillary Stability, Soft Tissue Healing, Graft Stability Measured at t5 (Month 6) and t6 (Month 9) Secondary: Bone Gain (assessed by CBCT) at t6, (Month 9) and Periotest Assessment (Clinically)
Other Data Variables: Follow-up assessments for complications, additional clinical and radiographic evaluations additional assessments (t4, Month 3; t5, Month 6)
The trial will employ various strategies to achieve adequate participant enrollment to reach the target sample size. These strategies will include:
B) Assignment of interventions 16. Allocation: 16a. Randomization:
16b. Allocation concealment mechanism: Allocation will be hidden behind sequentially numbered, opaque, sealed envelopes." An impartial researcher who is not engaged in participant recruitment, data collection, or evaluation will create the envelopes holding the randomized group allocations. At the time of treatment allocation, envelopes will be randomly mixed in a box and picked by participants.
16c. Implementation The principal researcher, who will be working under the supervision of the supervisor, is the one who will be responsible for enrolling participants and assigning people to receive intervention.
This is a double-blind experiment for the following reasons:
C) Data collection, management, and analysis:
Secondary outcomes were analyzed using set up tools and measures by blinded surgeons.
The patient's electronic data and scans will be stored on a One drive file to ensure backup and ease of access.
D) Data monitoring:
Potential problems:
To reduce risks:
To keep monitoring of potential risks:
Any major adverse occurrences will be reviewed by a data safety monitoring board.
IV. Ethics and dissemination 24. Research ethics approval The Ethics Committee of Scientific Research of the Faculty of Dentistry at Cairo University is going to review both this protocol and the informed consent form template.
Before enrolling, willing individuals will provide written informed permission. There will be consent forms accessible in Arabic. (mother language of the participants).
The monitoring will continue until all of the patients are happy.
EndNote Version 20
Our proposed study relies on EndNote version 20 for reference management and citation and bibliography accuracy. This software streamlines research by organizing the extensive library of academic materials on alveolar cleft bone graft repairs. A key function of EndNote is managing and categorizing references. Researchers can organize research articles, studies, and other academic resources. This feature is essential for organizing relevant literature for a complex study. Additionally, EndNote simplifies citation and bibliography creation. Research team collaboration is encouraged by the software. EndNote simplifies reference sharing for interdisciplinary studies like this, making it easier for researchers to collaborate.
V. Appendices 32. Informed consent
consent forms and other related documentation will be given to the participant's guardian. These will be fully explained, including details about the procedure, the intervention, and possible complications.
62 studies on the registry are indexed under Retrognathia; 15 are open to participants now.
This study's planned enrollment of 36 is close to the median of 34 across 52 interventional studies indexed under Retrognathia.
Browse Retrognathia studies →Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Eligibility criteria:
A suitable and representative sample will be selected by setting trial participant eligibility criteria. Mesa et al (2016) claimed that, the inclusion and exclusion criteria will consider demographics, disease severity, prior treatment, diagnostics, and other factors. This trial must balance accurately representing the target population with avoiding overly restrictive selection criteria.
Inclusion Criteria
Exclusion Criteria
Operator-dependent interventions will have clear eligibility criteria for care providers and centers to ensure consistency in administration. To improve external validity and clinical applicability, the trial will avoid overly restrictive participant selection (Sessler \& Imrey 2015; Aggarwal \& Ranganathan 2019). To ensure generalizability, trial participants must reflect the diversity of the target population.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Clinical Trial Intervention Description General Study Setup Objective: To compare the efficacy of using a custom-made prefabricated acrylic splint versus no splint in maintaining premaxillary stability post-alveolar cleft repair. Primary Outcome: Premaxillary stability. Secondary Outcomes: Wound healing and complications. Intervention Details 1. Common Procedures for Both Arms: Surgical Procedure: All surgical procedures will be conducted under general anesthesia with nasotracheal intubation. Antibiotic Prophylaxis: A first-generation cephalosporin will be administered prior to incision as per Bowder et al. (2021). Bone Graft Harvesting: Autogenous bone grafts will be harvested from the anterior iliac crest using a pediatric minimally invasive technique with a 2 cm skin incision 1 cm lateral to the iliac crest. Alveolar Cleft Repair: Incision and Flap Design: A sulcular incision will be made to develop full thickness mucoperiosteal advancement flaps extending into the cleft with care
Device: Clinical Trial Intervention Description General Study Setup Objective: To compare the efficacy of using a custom-made prefabricated acrylic splint versus no splint in maintaining premaxillary stabilit
Clinical Trial Intervention Description General Study Setup Objective: To compare the efficacy of using a custom-made prefabricated acrylic splint versus no splint in maintaining premaxillary stability post-alveolar cleft repair. Primary Outcome: Premaxillary stability. Secondary Outcomes: Wound healing and complications. Intervention Details 1. Common Procedures for Both Arms: Surgical Procedure: All surgical procedures will be conducted under general anesthesia with nasotracheal intubation. Antibiotic Prophylaxis: A first-generation cephalosporin will be administered prior to incision as per . Bone Graft Harvesting: Autogenous bone grafts will be harvested from the anterior iliac crest using a pediatric minimally invasive technique with a 2 cm skin incision 1 cm lateral to the iliac crest. Alveolar Cleft Repair: Incision and Flap Design: A sulcular incision will be made to develop full thickness mucoperiosteal advancement flaps extending into the cleft with caref
The primary outcome should be: Premaxillary stability vertical and horizontal assessed by (Lateral Cephalometric Analysis (Radiographically) at 6 months: Perform lateral cephalometric analysis using images generated from Cone Beam Computed Tomography (
Primary Outcome Measure: Outcome Measure Name: Premaxillary Stability Description: Assess the stability of the premaxilla both vertically and horizontally. Assessment Method: Lateral Cephalometric Analysis using images from Cone Beam Computed Tomography (CBCT). Time Frame: 6 months post-procedure. Units of Measure: Stability will be quantified in millimeters (mm) for both vertical and horizontal displacements.
Time frame: 6 MONTHS
Secondary Outcome Measures: Outcome Measure Name: 1) Soft Tissue Healing 2) Outcome Measure Name: Graft Stability
Secondary Outcome Measures: Outcome Measure Name: Soft Tissue Healing Description: Evaluate the healing of soft tissues surrounding the surgical site. Assessment Method: Clinical examination to assess signs such as erythema, edema, and wound dehiscence. Time Frame: At 1 week, 1 month, 3 months, and 6 months post-procedure. Units of Measure: Healing status categorized qualitatively as healed, healing, or not healed. Outcome Measure Name: Graft Stability Description: Determine the integration and stability of the bone graft. Assessment Method: Radiographic evaluation using X-rays or CBCT. Time Frame: 6 months post-procedure. Units of Measure: Stability reported qualitatively based on radiographic evidence
Time frame: 6 MONTHS
Stability will be quantified in millimeters (mm) for both vertical and horizontal displacements.
Stability will be quantified in millimeters (mm) for both vertical and horizontal displacements.
Time frame: 6 MONTHS
No study locations are listed for this record.
Plan to share: Undecided
No publications or documents are linked to this record.
Start is estimated for Feb 2025; primary completion for May 2025, 3 months later.
Of 30 interventional studies with no phase under Retrognathia, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 35. This study's planned 3 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.